Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function

CD4(+) recent thymic emigrants (RTEs) comprise a clinically and immunologically important T cell population that indicates thymic output and that is essential for maintaining a diverse alphabeta-T cell receptor (TCR) repertoire of the naive CD4(+) T cell compartment. However, their frequency and fun...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 206; no. 2; pp. 275 - 285
Main Authors Haines, Christopher J, Giffon, Thierry D, Lu, Li-Sheng, Lu, Xiaowei, Tessier-Lavigne, Marc, Ross, Douglas T, Lewis, David B
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 16.02.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CD4(+) recent thymic emigrants (RTEs) comprise a clinically and immunologically important T cell population that indicates thymic output and that is essential for maintaining a diverse alphabeta-T cell receptor (TCR) repertoire of the naive CD4(+) T cell compartment. However, their frequency and function are poorly understood because no known surface markers distinguish them from older non-RTE naive CD4(+) T cells. We demonstrate that protein tyrosine kinase 7 (PTK7) is a novel marker for human CD4(+) RTEs. Consistent with their recent thymic origin, human PTK7(+) RTEs contained higher levels of signal joint TCR gene excision circles and were more responsive to interleukin (IL)-7 compared with PTK7(-) naive CD4(+) T cells, and rapidly decreased after complete thymectomy. Importantly, CD4(+) RTEs proliferated less and produced less IL-2 and interferon-gamma than PTK7(-) naive CD4(+) T cells after alphabeta-TCR/CD3 and CD28 engagement. This immaturity in CD4(+) RTE effector function may contribute to the reduced CD4(+) T cell immunity observed in contexts in which CD4(+) RTEs predominate, such as in the fetus and neonate or after immune reconstitution. The ability to identify viable CD4(+) RTEs by PTK7 staining should be useful for monitoring thymic output in both healthy individuals and in patients with genetic or acquired CD4(+) T cell immunodeficiencies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
D. Ross's present address is Applied Genomics, Inc., Burlingame, CA 94010.
M. Tessier-Lavigne's present address is Genentech, Inc., San Francisco, CA 94080.
L.-S. Lu's present address is Medarex, Inc., Milpitas, CA 94043.
X. Lu's present address is Department of Cell Biology, University of Virginia, Charlottesville, VA 22908.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20080996